Manuel Gomez-Bueno
Overview
Explore the profile of Manuel Gomez-Bueno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heart transplant as treatment for cardiogenic shock: an effective strategy or a "Spanish exception"?
Hernandez-Perez F, Martin-Centellas A, Rivas-Lasarte M, Mitroi C, Gomez-Bueno M, Segovia-Cubero J
Rev Esp Cardiol (Engl Ed)
. 2025 Mar;
PMID: 40023487
Cardiogenic shock remains one of the main challenges in modern cardiovascular medicine. In Spain, urgent cardiac transplantation is the most widely used heart replacement therapy fin eligible patients who do...
2.
Perez-Blanco A, Gonzalez-Vilchez F, Gonzalez-Costello J, Royo-Villanova M, Minambres E, Cuenca J, et al.
Am J Transplant
. 2025 Feb;
PMID: 39993569
Heart transplantation from donors after the circulatory determination of death (DCDD) is expanding worldwide. Thoraco-abdominal normothermic regional perfusion (TA-NRP) allows the validation and recovery of the DCDD heart, but there...
3.
Dobarro D, Raposeiras-Roubin S, Almenar-Bonet L, Sole-Gonzalez E, Padilla-Lopez M, Diez-Lopez C, et al.
Life (Basel)
. 2025 Jan;
14(12.
PMID: 39768278
Heart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates. Most patients with ADHF never receive...
4.
de Frutos F, Saturi G, Gonzalez-Lopez E, Sguazzotti M, Dominguez F, Ponziani A, et al.
Amyloid
. 2024 Oct;
31(4):334-338.
PMID: 39449197
Introduction: Although sudden death (SD) is a recognized complication of cardiac amyloidosis, there is scarce data about its incidence, mechanisms, and predictors. The aim of this study was to describe...
5.
Enriquez-Vazquez D, Barge-Caballero E, Gonzalez-Vilchez F, Almenar-Bonet L, Garcia-Cosio Carmena M, Gonzalez-Costello J, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Oct;
PMID: 39393768
Introduction And Objectives: The impact of preoperative left ventricular (LV) unloading on postoperative outcomes in patients bridged with venoarterial extracorporeal membrane oxygenation (VA-ECMO) to heart transplantation (HT) is unknown. Our...
6.
Blasco-Turrion S, Crespo-Leiro M, Donoso Trenado V, Chi Hion P, Diaz Molina B, Roura G, et al.
Int J Cardiol
. 2024 Jul;
413():132340.
PMID: 38992809
Background: The current incidence and outcomes of structural transcatheter procedures in heart transplant (HTx) recipients and left-ventricular assist devices (LVAD) carriers is unknown. Aims: To provide insights on structural transcatheter...
7.
Gomez-Bueno M, Perez Gomez L, Hernandez Perez F, Mitroi C, Rivas Lasarte M, Segovia Cubero J
Rev Esp Cardiol (Engl Ed)
. 2024 May;
77(9):793-796.
PMID: 38763210
No abstract available.
8.
Rios-Tamayo R, Lecumberri R, Cibeira M, Gonzalez-Calle V, Alonso R, Domingo-Gonzalez A, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730641
Systemic AL amyloidosis is a challenging disease for which many patients are considered frail in daily clinical practice. However, no study has so far addressed frailty and its impact on...
9.
Segovia-Cubero J, Ruiz-Bautista L, Maiz-Carro L, Giron-Moreno R, Prados-Sanchez M, Martinez-Martinez M, et al.
Front Cardiovasc Med
. 2024 Feb;
11:1285223.
PMID: 38361580
Introduction: We conducted a study to determine the prevalence of structural heart disease in patients with CF, the characteristics of a cardiomyopathy not previously described in this population, and its...
10.
Gonzalez-Urbistondo F, Almenar-Bonet L, Gomez-Bueno M, Crespo-Leiro M, Gonzalez-Vilchez F, Garcia-Cosio M, et al.
Rev Esp Cardiol (Engl Ed)
. 2023 Nov;
77(4):304-313.
PMID: 37984703
Introduction And Objectives: Posttransplant outcomes among recipients with a diagnosis of hypertrophic cardiomyopathy (HCM) or restrictive cardiomyopathy (RCM) remain controversial. Methods: Retrospective analysis of a nationwide registry of first-time recipients...